ORPEA Has Taken Note of Information Published in Yesterday’s Press
ORPEA, a leader in dependency care, addressed public concerns regarding fraudulent activities previously reported to the Nanterre prosecutor's office. The company filed a criminal complaint on May 2, 2022, alleging it and its subsidiaries may have been victims of fraud. Currently, ORPEA has not identified any significant negative impact on its cash flow or real estate assets due to these activities. The company is committed to recovering any lost funds and has enhanced its internal controls. ORPEA will keep the market updated on the progress of its criminal complaint.
- No material negative impact on cash flow or real estate assets identified.
- Company is taking proactive steps to recover funds lost due to fraudulent activities.
- Strengthening of internal controls to prevent future fraud.
- Ongoing criminal investigations could affect company reputation.
The Company has taken note of information published in yesterday’s press.
The information refers to acts that were previously reported by the Company to the public prosecutor's office of
The Company has not currently identified any material negative impact on its cash flow or real estate assets as a result of the reported fraudulent activities. The Company intends to use all means at its disposal to recover the sums of money that it may have been deprived of as a result of these fraudulent acts.
Internal measures were immediately taken to remove the persons likely to be involved in these frauds and to strengthen the Group's internal control procedures.
At this stage, the Company does not have to make a determination as to the criminal nature of the facts it has denounced, nor on the responsibility of those involved.
The Company will keep the market informed of the outcome of its criminal complaint in accordance with corporate communication best standards and in compliance with its legal and regulatory obligations.
About
Founded in 1989,
View source version on businesswire.com: https://www.businesswire.com/news/home/20220518006179/en/
Investor Relations
EVP Communication and Investor Relations
s.grobet@orpea.net
Investor Relations Director
b.lesieur@orpea.net
Investor Relations
NewCap
Dusan Oresansky
+33 (0)1 44 71 94 94
orpea@newcap.eu
Media Relations
Image 7
+33 (0)6 78 37 27 60
clebarbier@image7.fr
+33(0)6 89 87 61 24
Caroline.simon@image7.fr
Source:
FAQ
What fraudulent activities is ORPEA involved in?
What is the status of ORPEA's criminal complaint?
Has ORPEA suffered financially from the reported fraudulent activities?
How is ORPEA addressing the reported fraud?